trial,pubID,pseudogroup,weeks,group,IgD-IgM-/IgA-/IgG+ B cells
G002,G002-852,3.0,16,1,628941.0
G002,G002-988,3.0,16,3,671092.0
G002,G002-577,4.0,16,2,634351.0
G002,G002-616,3.0,16,1,384106.0
G002,G002-931,3.0,16,3,657288.0
G002,G002-230,4.0,16,2,1584450.0
G002,G002-630,4.0,16,2,1810593.0
G002,G002-943,4.0,16,2,626591.0
G002,G002-678,3.0,16,1,476441.0
G002,G002-884,3.0,16,3,970934.0
G002,G002-796,3.0,16,3,443199.0
G002,G002-145,4.0,16,2,622076.0
G002,G002-997,3.0,16,3,697452.0
G002,G002-341,4.0,16,2,637824.0
G002,G002-119,4.0,16,2,491954.0
G002,G002-619,3.0,16,1,352901.0
G002,G002-304,3.0,16,3,84735.0
G002,G002-632,3.0,16,3,551737.0
G002,G002-855,4.0,16,2,1388779.0
G002,G002-820,4.0,16,2,1949527.0
G002,G002-427,3.0,16,3,738357.0
G002,G002-947,4.0,16,2,519278.0
G002,G002-758,3.0,16,1,291749.0
G002,G002-477,3.0,16,3,870594.0
G002,G002-866,3.0,16,3,2137700.0
G002,G002-969,3.0,16,1,1091179.0
G002,G002-302,3.0,16,1,644632.0
G002,G002-293,4.0,16,2,629631.0
G002,G002-546,3.0,16,1,893669.0
G002,G002-278,3.0,16,3,274473.0
G002,G002-620,4.0,16,2,426077.0
G002,G002-136,4.0,16,2,988040.0
G002,G002-595,3.0,16,3,1031544.0
G002,G002-813,3.0,16,1,78409.0
G002,G002-957,4.0,16,2,485824.0
G002,G002-462,3.0,16,3,517772.0
G002,G002-810,3.0,16,3,416699.0
G002,G002-516,3.0,16,1,595280.0
G002,G002-480,4.0,16,2,578425.0
G002,G002-493,4.0,16,2,214634.0
G002,G002-371,3.0,16,3,604758.0
G002,G002-905,3.0,16,1,587100.0
G002,G002-834,3.0,16,1,220830.0
G002,G002-825,3.0,16,3,310571.0
